ENTITY
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals (GNP IN)

169
Analysis
Health Care • India
Glenmark Pharmaceuticals Ltd., is a pharmaceutical company. The Company develops generic drugs for inflammation, metabolic disorders, and pain.
more
•30 Jun 2020 17:12

Glenmark Pharmaceuticals - Earnings Flash - Q4 And FY 2019-20 Results - Lucror Analytics

Glenmark Pharmaceuticals’ Q4/19-20 results were better than expected, with a turnaround in profitability. The improved performance was attributed...

Logo
384 Views
Share
•30 Jun 2020 14:56

Asia HY Trade Recommendations - June 2020 - Lucror Analytics

The Asia HY Trade Recommendations report for the month of June includes a summary of our recommendations. The report also features relative-value...

Logo
475 Views
Share
bullish•Softbank Group
•29 Jun 2020 08:57

Morning Views Asia: Glenmark Pharmaceuticals, Softbank Group

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region,...

Logo
318 Views
Share
bullish•Jubilant Pharma Ltd
•26 Jun 2020 10:43

Jubilant Pharma: Good Drugs, Fully-Valued Bonds

We initiate our coverage of Jubilant Pharma Ltd (1164252D IN) (JPL) which is ranked top 2-3 global pharmaceutical company in the...

Logo
520 Views
Share
bullish•Hilong Holding
•23 Jun 2020 08:52

Morning Views Asia: Fosun International, Glenmark Pharmaceuticals, Modernland Realty, Softbank Group

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region,...

Logo
421 Views
Share
x